(Aspirin Delayed Release Tablets, USP)
Enteric Coated Tablets

For arthritic pain and chronic pain... discover Easprin®

Easprin® (975 mg enteric coated aspirin, USP) is indicated in patients who need the higher 15-grain dose of aspirin in the long-term palliative treatment of mild or moderate pain and inflammation of arthritic and other inflammatory conditions.

Easprin®'s enteric coating acts to prevent the release of aspirin in the stomach, allowing the tablet to dissolve in the upper portion of the small intestine. This reduces any gastric irritation that may occur with uncoated aspirin, but it does not delay the onset of action.

Easprin® provides the relief of aspirin, one of the most widely used arthritic pain and chronic pain relievers on the market. In addition, Easprin® offers patients the convenience and practicality of 975 mg of aspirin in a single, delayed-released tablet, which may help to ensure proper schedules and better patient compliance.

Easprin® should not be taken by patients who are allergic to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) or by patients who have a history of recent gastrointestinal bleeding or other bleeding disorders (eg, hemophilia). Patients on anti coagulant therapy should use Easprin® with caution since aspirin may depress prothrombin concentration in the plasma and, as a consequence, bleeding time may be increased. Large doses of salicylates may enhance the effect of oral hypoglycemic agents, therefore, such doses should not be used, concomitantly. In addition, Easprin® should be used with caution in patients with asthma, nasal polyps, or nasal allergies.

The following adverse reactions to aspirin have been reported:

  • Gastrointestinal: Dyspepsia, nausea, vomiting, diarrhea, gastrointestinal bleeding, and/or ulceration.

  • Ear: Tinnitus, vertigo, reversible hearing loss.

  • Hematologic: Prologation of bleeding time, leukopenia, thrombocytopenia, purpura, decreased plasma iron concentration and shortened erythrocyte survival time.

  • Dermatologic and Hypersensitivity: Urticaria, angioedema, pruritus, various skin infections, asthma, and anaphylaxis.

  • Miscellaneous: Acute reversible hepatotoxicity, mental confusion, drowsiness, sweating, dizziness, headache, fever, thirst, and dimness of vision.

Easprin®, as a positioned market leader, has been chosen and trusted by physicians for more than 15 years. We are confident that you will find Easprin® to be an excellent therapy for mild to moderate arthritic pain, chronic pain, and inflammatory conditions.

For additional safety and prescribing information, please see package insert. If you have any questions concerning Easprin®, call us toll free at 1-800-247-4896.


REFERENCES

Fries, JF, Ramey DR, Singh G, Morfeld D, Bloch DA Raynauld JP. A Reevaluation of Aspirin Therapy in Rheumatoid Arthritis. Archives of Internal Medicine 1993; 153(21):2465-71

Pollet S, White RH, Jang H, Yim CW, Feigal D. Aspirin Dosing Using 15 Grain Enteric Coated Tablets. The Journal of Rheumatology 1985; 12(2): 341



© Copyright 2006 Rosedale Therapeutics. All Rights Reserved | Terms of Use | Privacy